• Return to Headlines

Synta Pharmaceuticals Up 24.1% Since SmarTrend Uptrend Call (SNTA)

Written on Thu, 01/10/2013 - 1:03pm
By David Diaz

SmarTrend identified an Uptrend for Synta Pharmaceuticals (NASDAQ:SNTA) on December 11th, 2012 at $8.44. In approximately 1 month, Synta Pharmaceuticals has returned 24.05% as of today's recent price of $10.47.

Over the past year, Synta Pharmaceuticals has traded in a range of $3.57 to $10.57 and is now at $10.47, 193% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.7% while the 200-day MA has risen 1.3%.

Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Synta Pharmaceuticals shares.

Log in and add Synta Pharmaceuticals (SNTA) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights synta pharmaceuticals

Ticker(s): SNTA

Contact David Diaz



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.